Classification
Product TypeIngredient
Product FormCrystalline Powder
Industry PositionDairy-Derived Food Ingredient and Pharmaceutical Excipient
Market
Lactose monohydrate in China is anchored by dual demand: food/infant nutrition use governed by the national food safety standard GB 25595-2018, and pharmaceutical excipient use aligned to pharmacopoeial expectations including the Chinese Pharmacopoeia lactose monohydrate monograph. Supply is tied to whey availability from China’s major raw-milk producing provinces in the north, with additional reliance on imports for some specifications and consistency requirements. China’s regulatory environment for imported food inputs is compliance-intensive, with overseas producer registration rules transitioning to GACC Decree No. 280 effective June 1, 2026 and managed through the CIFER system. Buyers commonly emphasize documentation, traceability, and contaminant control given the historical sensitivity of dairy-derived supply chains.
Market RoleLarge domestic consumer market with both domestic production and imports (import-reliant for some grades/specifications)
Domestic RoleWidely used industrial input for infant nutrition formulations, general food manufacturing, and as a pharmaceutical excipient in solid dosage forms
Specification
Physical Attributes- Pharmaceutical lactose monohydrate is commonly specified and supplied as a white, crystalline, free-flowing powder for oral solid dosage excipient applications.
Compositional Metrics- For food/infant use in China: conformity to GB 25595-2018 (National Food Safety Standard — Lactose).
- For pharmaceutical excipient use in China: pharmacopoeial conformity including Chinese Pharmacopoeia lactose monohydrate; IPEC cites ChP 2020 purity range of 98.0–102.0% (w/w) for pharmaceutical grade lactose.
Grades- Food-grade lactose for China market (GB 25595-2018)
- Pharmaceutical lactose monohydrate for China market (Chinese Pharmacopoeia monograph referenced by IPEC; market supply often supports multi-pharmacopoeia compliance)
Packaging- 25 kg multi-layer paper bags with PE inner liner are commonly used for pharmaceutical lactose monohydrate supplied into the China market (supplier standard packaging examples).
Supply Chain
Value Chain- Dairy processing whey/permeate stream (China northern dairy clusters) → concentration/oversaturation → lactose crystallization → refining and second crystallization (pharma grades) → drying/milling/sieving → bagging → importer/warehouse QA release → industrial users (infant nutrition, food manufacturing, pharmaceuticals).
Temperature- Suppliers marketing to China commonly recommend cool, dry storage and transport conditions for pharmaceutical-grade lactose (example guidance: <27°C and <65% RH), with supplier-specific specifications prevailing.
Atmosphere Control- Moisture control is critical in China distribution to prevent caking and protect flow/compressibility performance in pharmaceutical and infant-nutrition applications.
Shelf Life- Commercial pharmaceutical lactose products marketed in China commonly carry multi-year shelf life (often 24–36 months) subject to packaging integrity and storage conditions.
Freight IntensityMedium
Transport ModeSea
Risks
Regulatory Compliance HighFailure to meet China’s overseas producer registration and declaration requirements (managed in CIFER and transitioning under GACC Decree No. 280 effective June 1, 2026) can block or suspend imports of lactose monohydrate intended for food processing or consumption in China.Confirm the product’s China category assignment and ensure CIFER registration status, documentation, and customs declaration fields are aligned before booking shipment; monitor GACC transition guidance around June 1, 2026.
Food Safety MediumChina’s dairy-derived supply chains remain highly sensitive to deliberate adulteration risks due to the 2008 melamine-tainted infant formula crisis; buyers may impose intensified contaminant testing and supplier audits for dairy derivatives including lactose.Implement enhanced supplier qualification (audit + traceability), require contaminant-focused COAs, and use accredited third-party verification for high-risk channels (infant nutrition, pharma).
Documentation Gap MediumLabeling and documentation noncompliance is a common trigger for import noncompliance findings in China; for prepackaged foods GB 7718-2025/GB 28050-2025 requirements apply with stated transition periods, and imported foods must present Chinese-compliant labeling where required.Perform pre-shipment label and document review against the intended sales format (consumer vs industrial prepack) and keep a China-importer-approved checklist tied to GB standards and shipment usage.
Logistics MediumPowder moisture exposure during ocean transit and China domestic warehousing can cause caking and degrade flow/compressibility performance, impacting pharmaceutical and infant-nutrition manufacturing performance and increasing rejection risk.Use moisture-barrier packaging and desiccant/liner controls as appropriate, maintain dry warehousing, and align storage conditions with supplier stability guidance (including temperature/RH limits).
Sustainability- Animal-origin (whey-derived) traceability expectations for lactose used in China food/infant and pharmaceutical supply chains
Standards- IPEC-PQG GMP Guide for Pharmaceutical Excipients (commonly referenced by pharmaceutical lactose manufacturers; supports change control and distribution expectations)
FAQ
Which China standard anchors food/infant-use lactose requirements?China’s National Food Safety Standard GB 25595-2018 (乳糖) defines lactose for food and infant consumption, including recognition of anhydrous and monohydrate forms, and is the core conformity reference for food-grade lactose used in China.
What is the biggest compliance risk that can stop lactose monohydrate imports into China?A common deal-breaker is overseas producer registration and declaration noncompliance: China manages overseas food establishment registration through the CIFER system, and the rules are transitioning under GACC Decree No. 280 effective June 1, 2026. If the correct registration status/number and supporting compliance documentation are missing or misapplied, shipments can be blocked or suspended.
Why do buyers emphasize contaminant controls for dairy-derived ingredients in China?China’s dairy supply chain has a well-known food safety legacy from the 2008 melamine-tainted infant formula crisis. Even when sourcing lactose as a refined ingredient, many buyers maintain heightened diligence (audits, traceability, and contaminant-focused testing) for dairy-derived inputs.
What packaging format is commonly used for pharmaceutical lactose monohydrate supplied into China?Supplier examples marketed to China commonly use 25 kg multi-layer paper bags with a PE inner liner (and, depending on supplier/product, additional barrier layers). Exact packaging and storage specifications should be confirmed in the supplier’s quality and regulatory documentation.